Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) has been given an average rating of “Buy” by the six ratings firms that are covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $10.00.
Several equities research analysts recently weighed in on the stock. Lake Street Capital cut their price objective on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research report on Friday. Canaccord Genuity Group cut their price target on shares of Bioceres Crop Solutions from $9.50 to $7.00 and set a “buy” rating for the company in a report on Friday. Finally, Oppenheimer decreased their price objective on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 28th.
Institutional Investors Weigh In On Bioceres Crop Solutions
Bioceres Crop Solutions Stock Down 0.5 %
Shares of BIOX opened at $5.55 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a 12 month low of $5.50 and a 12 month high of $14.05. The firm’s 50 day moving average is $6.65 and its 200-day moving average is $7.86. The stock has a market capitalization of $348.04 million, a PE ratio of 277.64 and a beta of 0.57.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The company had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter last year, the business earned ($0.07) EPS. Equities research analysts forecast that Bioceres Crop Solutions will post 0.12 EPS for the current year.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Articles
- Five stocks we like better than Bioceres Crop Solutions
- Options Trading – Understanding Strike Price
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Technology Stocks Explained: Here’s What to Know About Tech
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.